Combination panobinostat and olaparib treatment promotes DNA damage and antitumor immunity in ovarian cancer.

Wilson, AJ; Dai, XZ; Liu, Q; Hiebert, S; Crispens, M; Khabele, D

CLINICAL CANCER RESEARCH, 2020; 26 (13): 54

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索